KAREN CONNER: Open Payments
NPI 1669879771 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 75 payments from 13 companies in 2025. Trend: 2023 $566 · 2024 $1,217 · 2025 $1,837
Food & beverage: $1,704Education: $132
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $355 |
| Novartis Pharmaceuticals Corporation | 15 | $319 |
| AstraZeneca Pharmaceuticals LP | 8 | $287 |
| GlaxoSmithKline, LLC. | 7 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $141 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $93 |
| Genentech USA, Inc. | 3 | $93 |
| CSL Behring | 3 | $82 |
| BioCryst US Sales Co., LLC | 3 | $74 |
| GENZYME CORPORATION | 3 | $61 |
Products named: DUPIXENT, XOLAIR, NUCALA, BREZTRI, Rhapsido, NEFFY, ORLADEYO, FASENRA.
Industry payments across NM — which companies pay providers there.
